Immunity Project
FoundationYC W14San Francisco, US · Founded 2013 · 11 employees · Nonprofit · 2 known investors
Find your way into Immunity Project
Sign up to see every warm intro you have to Immunity Project
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Immunity Project team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Immunity Project is a non-profit initiative developing an HIV vaccine aimed at curing HIV and AIDS. It intends to distribute the vaccine for free pending success in clinical trials.
Also known as Until There's A Cure Foundation
AI & Machine LearningBiotechHealthtechImpact & Social GoodHealth TechUnited States of AmericaAmerica / Canada
Founders & leadership· Y Combinator alumni (W14)
Immunity Project was founded in 2013 by Naveen Jain, Reid Rubsamen, and Ian Cinnamon.
RR

Reid RubsamenCo-FounderReid Rubsamen is a board-certified anesthesiologist with an M.D. from Stanford University and advanced degrees in computer science from MIT and healthcare management from Harvard; he previously founded Aradigm Corporation and Flow Pharma after postdoctoral work at MIT's Laboratory for Computer Science, and holds over 70 U.S. patents.
Investors · 2
Founder mafia
3 people who came through Immunity Project went on to found or lead other companies.
Related companies · 3
FrekilFrekil automates real-world evidence generation for pharmaceutical and healthcare research, using AI agents to build patient cohorts, design studies, and generate statistical analyses from existing clinical data. The platform enables epidemiological workflows across drug safety monitoring, comparative effectiveness, label expansion, and trial feasibility assessments.
Illume LabsIllume Labs aggregates data from wearables, blood tests, and genomic sequencing to deliver personalized health insights via text message and conversational AI, helping users understand changes in their health metrics and receive actionable recommendations.
Probably GeneticProbably Genetic operates a data platform that finds undiagnosed patients with severe, complex genetic diseases online and analyzes their condition using machine learning and at-home testing. The platform is used by drug developers and patient advocacy groups to help patients access diagnoses, clinical trials, and treatments earlier.
Companies working in the same space as Immunity Project.
Legal entities · 1
corporate structureUntil There's A Cure Foundation
Frequently asked questions
- What does Immunity Project do?
- Immunity Project is a non-profit initiative developing an HIV vaccine aimed at curing HIV and AIDS. It intends to distribute the vaccine for free pending success in clinical trials.
- Who founded Immunity Project?
- Immunity Project was founded by Naveen Jain, Reid Rubsamen, Ian Cinnamon in 2013.
- Who are Immunity Project's investors?
- Immunity Project's investors include Ranch Ventures, Y Combinator.
- Where is Immunity Project headquartered?
- Immunity Project is headquartered in San Francisco, US.






